Utility of glypican-3, alpha-fetoprotein, and HepPar-1 as a panel for detecting hepatocellular carcinoma in fine needle aspiration biopsies

被引：0
|
作者：
LaCaria, T. M. [1 ]
Teot, L. A. [1 ]
Cai, G. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
349
引用
收藏
页码：78A / 78A
页数：1
相关论文
共 46 条
  • [1] Utility of glypican-3, alpha-fetoprotein, and HepPar-1 as a panel for detecting hepatocellular carcinoma in fine needle aspiration biopsies
    LaCaria, T. M.
    Teot, L. A.
    Cai, G.
    LABORATORY INVESTIGATION, 2008, 88 : 78A - 78A
  • [2] Arginase-1, HepPar-1, and Glypican-3 Are the Most Effective Panel of Markers in Distinguishing Hepatocellular Carcinoma From Metastatic Tumor on Fine-Needle Aspiration Specimens
    Timek, Dana T.
    Shi, Jianhui
    Liu, Haiyan
    Lin, Fan
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (02) : 203 - 210
  • [3] Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies
    Fujiwara, Mika
    Kwok, Shirley
    Yano, Hirohisa
    Pai, Reetesh K.
    CANCER CYTOPATHOLOGY, 2012, 120 (04) : 230 - 237
  • [4] Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver
    Ibrahim, Taiseer R.
    Abdel-Raouf, Samar M.
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (02) : 379 - 387
  • [5] Review Article Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma
    Dominguez-Lazcano, Diana Gabriela
    Simon-Lara, Ingrid
    Morales-Romero, Jaime
    Vasquez-Garzo, Veronica Rocio
    Arroyo-Helguera, Omar Elind
    Lopez-Vazquez, Julieta
    Campos-Parra, Alma D.
    Hernandez-Nopaltecatl, Brayan
    Rivera-Hernandez, Ximena Andrea
    Quintana, Sofia
    Garcia-Roman, Rebeca
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2024, 17 (11): : 383 - 395
  • [6] The use of HepPar-1 in distinguishing common and uncommon metastatic liver lesions from hepatocellular carcinoma in fine needle aspiration
    Massoll, NA
    Brown, HM
    LABORATORY INVESTIGATION, 2002, 82 (01) : 80A - 80A
  • [7] A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
    Cheng Xu
    Zhehui Yan
    Liang Zhou
    Yuming Wang
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1417 - 1424
  • [8] A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
    Xu, Cheng
    Yan, Zhehui
    Zhou, Liang
    Wang, Yuming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1417 - 1424
  • [9] Glypican-3 versus alpha-fetoprotein as a biomarker for hepatocellular carcinoma: a diagnostic meta-analysis
    Fu, Weiyu
    Lu, Hongyu
    Li, Li
    Wu, Kefeng
    Li, Yanping
    Liu, Yi
    Hu, Jianli
    BIOCELL, 2015, 39 (2-3) : 25 - 31
  • [10] The use of HepPar-1 in distinguishing common and uncommon metastatic liver lesions from hepatocellular carcinoma in fine needle aspiration
    Massoll, NA
    Brown, HM
    MODERN PATHOLOGY, 2002, 15 (01) : 80A - 80A
12345